Trials / Unknown
UnknownNCT05510648
Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis
The Effect of High-intensity Laser Therapy in Knee Osteoarthritis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Necmettin Erbakan University · Academic / Other
- Sex
- All
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effects of high intensity laser therapy (HILT) on range of motion, pain, quality of life, muscle strength and femoral cartilage thickness in patients with knee osteoarthritis.
Detailed description
Patients who are admitted and diagnosed with knee osteoarthritis based on anamnesis, physical examination and imaging methods are included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | high-intensity laser therapy | A total of 15 sessions of hotpack, TENS and exercise program will be applied to the patients for three weeks, 5 days a week, 1 session a day. The patients in the HILT group will be treated with a BTL 6000 brand device (Figure 5) for 3 sessions of high-intensity laser with a power of 10.0 w in the first week, energy density of 12 j/cm², every 25 cm² for 2 minutes in analgesic mode, and 5 sessions in the following 2 weeks. While 6 sessions of .0 w power, energy density of 120 j/cm², each 25 cm² for 10 minutes, will be applied in biostimulant mode for 6 sessions for three weeks, is applied in analgesic mode for 3 sessions every other day in the first week, and 6 sessions every other day in the biostimulant mode for the next two weeks, for a total of 9 sessions for three weeks. |
| OTHER | sham high-intensity laser therapy | Hotpack, TENS and exercise program applications will be applied to the patients in the same way as in the HILT group, 5 days a week, 1 session a day, a total of 15 sessions for three weeks. HILT is administered as a placebo for three weeks, 3 sessions a week, every other day, for a total of 9 sessions. |
Timeline
- Start date
- 2022-09-25
- Primary completion
- 2022-09-25
- Completion
- 2022-11-25
- First posted
- 2022-08-22
- Last updated
- 2022-09-28
Source: ClinicalTrials.gov record NCT05510648. Inclusion in this directory is not an endorsement.